Skip to main content
search

bioscrip

By March 19, 2015Headlines

In an investment that may not suit it to a "t", Bioscrip has raised $62.5 million in a private placement of convertible notes to support its prescription home infusion business.

http://www.prnewswire.com/news-releases/bioscrip-raises-625-million-in-private-placement-of-convertible-preferred-stock-and-announces-plan-for-20-million-rights-offering-300047294.html

Tags:

Related Posts

Headlines
February 6, 2024

Cano

Cano Health apparently cannot, as it declares bankruptcy due to too much debt.  Building primary…
Kevin Roche 0
Headlines
January 24, 2024

Turquoise

Turquoise health raises a fresh $30 million in capital for its price transparency platform, as…
Kevin Roche 0
Headlines
January 24, 2024

CAR-T safety

I am co-f0under of a company that manages cell and gene therapy for health plans.…
Kevin Roche 0

Leave a comment

Close Menu